ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267052.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.038073665	Resistant
ENSG00000267052.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.045563514	Resistant